Authors
Latest:
The shifting landscape of conjunctival hyperemiaEuropean patients navigate new therapies and market change-ups
Latest:
The ins and outs of gene therapy for inherited optic neuropathiesA look at what’s in the therapeutic delivery pipeline for these disorders.
Latest:
Rethinking race as a risk factor for glaucomaSocial determinants of health challenge our existing expectations
Latest:
Shining new light on ocular surface careLow-level light therapy for dry eye disease and chalazion
Latest:
Keratoconus: Intrastromal implantation of fresh human lenticulesStromal regeneration seems possible in patients with keratoconus.
Latest:
Paying attention to ocular surface disease preoperatively mattersLook for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.
Latest:
The “fourth dimension” of home monitoringA longitudinal, AI-based approach to fluid quantification
Latest:
Understanding the molecular mechanisms underlying cataract developmentA greater understanding of lens embryology and the phenotype/genotype correlation of cataracts should help guide future therapeutic approaches.
Latest:
For younger patients with mid-range myopia, consider phakic IOLsThe implantable lenses can offer an advantage over laser surgery
Latest:
How to use topography-guided laser procedures to treat keratoconusTopography-guided PRK, with or without the addition of corneal crosslinking, can improve visual acuity and quality in patients with keratoconus.
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNewly developed acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Extended depth-of-field IOLs: Clarification of current nomenclatureClinicians and surgeons should be aware of the misleading use of the EDOF concept. The authors herein propose an alternative terminology and that lenses which have combined optical designs are referred to as ‘hybrid IOLs’.
Latest:
The CHAMP clinical trial and NVK002 for controlling paediatric myopiaDetermining the medication’s safety and efficacy for paediatric patients
Latest:
Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditionsClinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Latest:
A new route to reducing IOPTo date, the suprachoroidal space has not been a feasible route to reduce intraocular pressure in glaucoma. A new device promises to change that.
Latest:
Using pivotal study data to guide glaucoma patient management decisionsTwo randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Latest:
Surgical management of posterior uveitis in childrenVitrectomy is a tool that can help surgeons curb complications
Latest:
Helping patients with glaucoma manage mental healthThe link between eye health and mental health may be deeper than previously believed
Latest:
The consequences of dry eye disease: incidence of psychiatric disorders, fibromyalgia and chronic fatigue following diagnosisDry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 AAO meeting
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
Latest:
Uveitis: A leading and underestimated cause of visual morbidity in patientsOphthalmologists are seeking improved treatment options for uveitis as epidemiological studies demonstrate the scope and sight-stealing burden of the disease.
Latest:
Up for debate: Clinicians take on hot topics at the Congress on Controversies in OphthalmologyThis year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain
Latest:
Amblyopia screening with the dynamic random dot stereotestA new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.
